Who is sponsoring NCT07025135?

NCT07025135 is sponsored by Medical University of Gdansk.

What drugs are being tested in NCT07025135?

Interventions in NCT07025135: comparison between use of mobile app, Patient-caregiver dyad using printed recommendations.

What condition does NCT07025135 study?

NCT07025135 studies Constipation - Functional.

Is NCT07025135 still recruiting?

NCT07025135 is currently completed. Last updated 17 June 2025.

Last reviewed 2025-06-17 · How we verify

NCT07025135

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Effectiveness of a Mobile Application in the Treatment of Children With Functional Constipation

Completed NA Last updated 17 June 2025

What this trial tests

NA trial testing comparison between use of mobile app in Constipation - Functional in 100 participants. Completed in 30 June 2024.

Timeline

5 February 2023

Primary endpoint
30 June 2024

30 June 2024

Quick facts

Lead sponsor	Medical University of Gdansk
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	100
Start date	5 February 2023
Primary completion	30 June 2024
Estimated completion	30 June 2024
Sites	1 location across Poland

Drugs / interventions tested

comparison between use of mobile app
Patient-caregiver dyad using printed recommendations

Conditions studied

Constipation - Functional — all drugs for Constipation - Functional →

Sponsor

Medical University of Gdansk

Who can join

Adults 4 to 18, any sex, with Constipation - Functional. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized, double-blind clinical trial evaluates the effectiveness of use of a mobile health application in supporting the treatment of functional constipation in children aged 4 to 18 years. Participants are randomly assigned ( with en-bloc randomization) to either an intervention group using an interactive app with symptom tracking, reminders, and games or a control group using equivalent, but printed materials. The primary outcome is the improvement in constipation symptoms after 3 months with follow-up after 6 months (+/- 30 days) after enrollment. Secondary outcomes include achieving regular bowel movements. The study aims to determine whether digital tools can enhance treatment adherence and clinical outcomes in pediatric functional constipation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Mobile app improves treatment of functional constipation in children: a randomized single-blind study.
Leszkowicz J, Nazar W, Wysokińska-Zakrzewska K, Zdun-Ryżewska A, et al · · 2025 · PMID 41366315 · DOI 10.1186/s12887-025-06385-y

Verify or expand the search:

Other recruiting trials for Constipation - Functional

Currently open trials in the same condition.

NCT07300423 — Parents of Children With Constipation Will be Asked About Their Views on Their Children's Physical Activity. · recruiting
NCT07126327 — Peristeen Light Explorative Clinical Investigation · NA · recruiting
NCT07387952 — The Safety and Efficacy of Fecal Microbiota Transplantation Combined With Nutritional Intervention in the Treatment of F · NA · recruiting
NCT07340203 — Cross-Cultural Adaptation, Validity, and Reliability of the Wexner Questionnaire in Patients With Constipation · active not recruiting
NCT07077044 — The Effects of TTNS, TTNS Combined With PHUS, and Conventional Therapy With PHUS in the Treatment of PFC. · NA · recruiting

Other Medical University of Gdansk trials

Trials by the same sponsor.

NCT07521280 — State-Based Rehabilitation for Youth Athletes With Osgood-Schlatter or Sever-Related Apophyseal Pain · NA · not yet recruiting
NCT07446517 — Low-Level Laser Therapy for Osgood-Schlatter or Sever Pain in Youth Athletes · NA · recruiting
NCT07449585 — Pericapsular Nerve Group Block Versus Intrathecal Morphine for Analgesia After Total Hip Arthroplasty · NA · not yet recruiting
NCT07397208 — Assessment of the Repeatability of Sublingual Microcirculation Function Measurements in Healthy Volunteers and Criticall · not yet recruiting
NCT07345403 — GENECARD - the Use of Genetic, Epigenetic, Metabolomic, Proteomic and Microbiotic Markers, Image and Voice Biomarker Ana · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07025135 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Gdansk
Last refreshed: 17 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07025135.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing